Search
Search Results
-
Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40–60 years: a cross-sectional study
BackgroundMenopause is a specific physical and psychological transition period for women, during which they experience a series of menopausal...
-
Menopausal Hormone Therapy in Older Women: Examining the Current Balance of Evidence
Menopause occurs in all women. During the menopause transition, 80% of women experience vasomotor symptoms that can last an average of 7–10 years or...
-
Long-term breast cancer incidence trends by mammography, obesity, and menopausal hormone therapy
PurposeOver the past half century, the annual age-adjusted breast cancer incidence in the USA has fluctuated, potentially influenced by changes in...
-
Antiosteoporosis therapy after discontinuation of menopausal hormone therapy: a systematic review
ObjectiveMenopausal hormone therapy (MHT) has consistently shown a bone protective effect by reducing the risk of vertebral, non-vertebral, and hip...
-
Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review
Menopause is accompanied by several metabolic adaptations, which are related to insulin resistance, increased total body fat mass, and central...
-
Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case–control study in Sweden
Sarcoidosis incidence peaks in women between 50 and 60 years old, which coincides with menopause, suggesting that certain sex hormones, mainly...
-
Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials
SummaryIn a combined analysis of 25,389 postmenopausal women aged 50–79 years, enrolled in the two Women’s Health Initiative hormone therapy trials,...
-
Using menopausal hormone therapy after a cancer diagnosis in Ireland
BackgroundMenopause may cause a constellation of symptoms that affect quality of life. Many women will have menopause induced or exacerbated by...
-
Menopausal hormone therapy, oral contraceptives and risk of chronic low back pain: the HUNT Study
BackgroundThere are indications that use of menopausal hormone therapy (MHT) and oral contraceptives (OC) increases the risk of low back pain (LBP),...
-
Effects of Hormone Replacement Therapy on Women's Lung Health and Disease
This review provides an overview of menopausal hormone therapy and pulmonary disease risk, with a focus on the effect of hormone replacement therapy...
-
The menopausal transition period and cardiovascular risk
The menopausal transition period spans, on average, 2–8 years before the final menstrual period and is associated with an increase in clinical and...
-
The effect of hormone therapy on physiological uptake of the endometrium on [18F]F-FDG PET in postmenopausal women
ObjectiveThe effects of hormonal therapy, estrogen-based hormone replacement therapy (HRT), and anti-tumor hormone therapy, such as tamoxifen, on the...
-
Menstrual Phase and Menopausal Status Classification of Benign Breast Tissue Using Hormone-Regulated Gene Expression and Histomorphology: A Validation Study
BackgroundThe validation of breast cancer risk biomarkers in benign breast samples (BBS) is a long-sought goal, hampered by the fluctuation of gene...
-
The effect of menopausal hormone therapy on gastrointestinal cancer risk and mortality in South Korea: a population-based cohort study
BackgroundThe effect of menopausal hormone therapy (MHT) on gastrointestinal (GI) cancers is controversial, and no research has been conducted in the...
-
Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses’ Health Studies
PurposePhysical activity is associated with lower breast cancer risk, especially in postmenopausal women. Associations in premenopausal women are...
-
Menopausal Hormonal Therapy and Breast Cancer
AbstractThe most common treatment for menopausal syndrome is menopausal hormone therapy (MHT), however, the safety of MHT, due to the risk of...
-
Hormone replacement therapy in BRCA mutation carriers: how shall we do no harm?
Women with a BRCA mutation have an increased risk of develo** breast and ovarian cancer. Bilateral sal**o-oophorectomy is the only effective...
-
A survey about the awareness among the physiotherapists in the use of Matrix Rhythm Therapy in treating chronic low back pain in post-menopausal women
BackgroundMenopause is a stage in a woman's physiology where several chronic illnesses begin to appear, compromising both the quality and quantity of...
-
Factors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer
PurposeWeight gain after breast cancer poses health risks. We aimed to identify factors associated with weight gain during adjuvant endocrine therapy...
